top
Search terms
Results 1 - 10 of 61 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 7
Ehjournal

Abstract Aims Although non-vitamin K antagonist oral anticoagulants are recommended for stroke prevention in patients with non-valvular atrial fibrillation (NVAF) based on clinical trial results, ...

European Heart Journal, FASTTRACK ESC Clinical Registry, A. John Camm, Pierre Amarenco, Sylvia Haas, Susanne Hess, Paulus Kirchhof, Silvia Kuhls, Martin van Eickels, Alexander G.G. Turpie

Date : 07/04/2016 Item size : 258982 bytes
Eurointervention

Medical Clinic I, Städtische Kliniken Neuss, Lukaskrankenhaus GmbH, Neuss, Germany Aims: The aim of this study was to determine the opinion of the scientific community regarding percutaneous left ...

Date : 16/05/2016 Item size : 34612 bytes
Epeuropace

Phase I, baseline cohort before the introduction of non-VKA oral anticoagulants (NOACs); Phase II, just after the introduction of the first NOAC dabigatran, with 2-year follow-up in ...

Europace, CLINICAL RESEARCH, Menno V. Huisman, Chang Sheng Ma, Hans-Christoph Diener, Sergio J. Dubner, Jonathan L. Halperin, Kenneth J. Rothman, Christine Teutsch, Nils Schoof, Eva Kleine, Dorothee ...

Date : 01/09/2016 Item size : 261631 bytes
Epeuropace

The aim of this study was to assess the effectiveness and safety of dabigatran (direct thrombin inhibitor) vs. acenocoumarol (vitamin K antagonist) in patients with atrial fibrillation (AF) in daily ...

Europace, CLINICAL RESEARCH, Jennie Korenstra, E. Petra J. Wijtvliet, Nic J.G.M. Veeger, Christiane A. Geluk, G. Louis Bartels, Jan L. Posma, Margriet Piersma-Wichers, Isabelle C. Van Gelder, Michiel ...

Date : 01/09/2016 Item size : 247506 bytes
Epeuropace

Patients’ attitude and knowledge about oral anticoagulation therapy: results of a self-assessment survey in patients with atrial fibrillation conducted by the European Heart Rhythm ...

Europace, EHRA SURVEY, Walid Amara, Torben B. Larsen, Elena Sciaraffia, Antonio Hernández Madrid, Jian Chen, Heidi Estner, Derick Todd, Maria G. Bongiorni, Tatjana S. Potpara, Nikolaos Dagres, ...

Date : 01/01/2016 Item size : 171968 bytes
Epeuropace

Preference for oral anticoagulation therapy for patients with atrial fibrillation in Europe in different clinical situations: results of the European Heart Rhythm Association Survey Abstract The ...

Europace, EP WIRE, Torben Bjerregaard Larsen, Tatjana Potpara, Nikolaos Dagres, Alessandro Proclemer, Elena Sciarrafia, Carina Blomström-Lundqvist

Date : 01/05/2015 Item size : 161520 bytes
Epeuropace

Abstract The purpose of this EP wire survey was to assess clinical practice in relation to the use of left atrial appendage occlusion (LAAO) devices for stroke prevention in atrial fibrillation (AF) ...

Europace, EP WIRE, Gregory Y.H. Lip, Nikolaos Dagres, Alessandro Proclemer, Jesper Hastrup Svendsen, Laurent Pison, Carina Blomstrom-Lundqvist, conducted by the Scientific Initiative ...

Date : 01/01/2013 Item size : 149356 bytes
Ehjcvp

Abstract Aims We aimed to evaluate bleeding risk in clinical practice in patients with atrial fibrillation (AF) being prescribed dabigatran, rivaroxaban, or apixaban compared with warfarin. Using a ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Article, Sigrun Halvorsen, Waleed Ghanima, Ingunn Fride Tvete, Cecilie Hoxmark, PÃ¥l Falck, Oddvar Solli, Christian Jonasson

Date : 01/01/2017 Item size : 240628 bytes
Epeuropace

When a clinician has to decide on use of antithrombotic drugs in the setting of a patient affected by atrial fibrillation (AF) experiencing an acute coronary syndrome (ACS), the difficult task is ...

Europace, Editorial, Giuseppe Boriani, Deirdre A. Lane, Stephan Windecker, Kurt Huber, Paulus Kirchhof, Gregory Y.H. Lip

Date : 01/09/2015
Heart

Keitaro Senoo1, Gregory Y H Lip1,2 1University of Birmingham, Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK 2Aalborg Thrombosis Research Unit, Department of Clinical Medicine, ...

Heart, Editorial, Keitaro Senoo, Gregory Y H Lip

Date : 01/06/2015